Testing effectiveness (Phase 2)Study completedNCT02861586
What this trial is testing
Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine
Who this might be right for
Chikungunya Virus Infection
Themis Bioscience GmbH 263
Showing 20 of 0 results